OncLive | Bringing the Global Oncology Community Together

Entrectinib received its first regulatory approval, as Japan’s Ministry of Health, Labour and Welfare has approved the drug for the treatment of adult and pediatric patients with NTRK fusion–positive, advanced... Read More >>

Frontline Maintenance Olaparib Approved in Europe for Ovarian Cancer

FDA Approves Pembrolizumab for Metastatic SCLC

Pfizer Acquires Array BioPharma in $11.4 Billion Deal

Single-Agent Acalabrutinib Showcases Potential Practice-Changing Data in Relapsed/Refractory CLL

Optimizing Treatment Approaches for Chronic Lymphocytic Leukemia

View More Stories >>

View Conference Coverage

2019 State of the Science Summit on Hematologic Malignancies in Pittsburgh

2019 State of the Science Summit on Hematologic Malignancies in Seattle

15th International Conference on Malignant Lymphoma

2019 European Hematology Association Congress

2019 ASCO Annual Meeting

Dr. Gadgeel on Updated KEYNOTE-189 Data in NSCLC

Dr. Jain on Results of Gender Disparities Study in Oncology

Dr. Fidler on Novel Chemotherapy Strategies in Nonsquamous NSCLC

Dr. Ou on the FDA Approval of Pembrolizumab in SCLC

Dr. Kumthekar Discusses Frontline Therapy for Anaplastic Astrocytoma

Dr. Bekaii-Saab on Tolerability of Encorafenib, Binimetinib, and Cetuximab in BRAF+ CRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Hairy Cell Leukemia: Incidence and Presentation

Rationale for Immunotherapy in Ovarian Cancer

Ovarian Cancer: Recurrence After PARP Inhibition

Ovarian Cancer: Predictors of PARP Sensitivity

Ovarian Cancer: Selecting Between Available PARPs

Precision Medicine in Oncology: Overcoming Obstacles

OncLive houses thousands of videos that provide updates and information.
See more Videos

Hepatocellular Carcinoma: AFP's Role as a Biomarker

Progress in the Management of Hepatocellular Carcinoma

Minimizing Adverse Effects of Chemoradiotherapy

Radiation Therapy: Dosing, Scheduling, & Toxicity Management

Radiation Therapy Eligibility for Stage III NSCLC

Management of PARP Inhibitor AEs in Ovarian Cancer

Impact of SOLO-1 on Advanced Ovarian Cancer Management

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

New Directions in Chronic Lymphocytic Leukemia Care: A Review of 2019 Treatment Guideline Updates

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

TRK Inhibitors: Precision Medicine in Oncology

Benjamin Levy, MD; Mark Agulnik, MD; Marcia Brose, MD, PhD; Edward Kim, MD; John Marshall, MD; and Philip Agop Philip, MD, PhD, FRCP, discuss the use of TRK inhibitors in oncology.

View more >>>

Featured Video

Advances in BRAF-Targeted Therapy for Metastatic Melanoma

Novel Combination Approaches for Metastatic Kidney Cancer

Geoffrey Thomas Gibney, MD; Ryan J. Sullivan, MD; Hussein A. Tawbi, MD, discuss advances in BRAF-targeted therapy for patients with metastatic melanoma. View now

FDA Approvals in HNSCC and DLBCL, and Encouraging Data in CLL, MDS, and CMML